Test Price
2,700 AEDโ Home Collection Available
Cancer Targeted Gene Panel (Colon/Colorectal) โ NGS & IHC Profiling in Dubai, UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (NGS + IHC + Fragment/STR Analysis).
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval โ archival FFPE block or slides, shipped at room temperature. Mobile home phlebotomy is disabled for this test.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by our specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Cancer Targeted Gene Panel (Colon/Colorectal) is a comprehensive molecular profiling test that analyzes tumor tissue for actionable genetic mutations, guiding personalized oncology therapies. This NGS-based panel, combined with IHC validation and fragment/STR analysis, identifies markers like KRAS, NRAS, BRAF, and MSI status critical for colorectal cancer management and prognosis.
| Feature | Our Test (Gene Panel) | Closest Alternative (Single Gene Tests) |
|---|---|---|
| Precision | Comprehensive NGS with IHC and fragment analysis, >99% sensitivity | Limited to one gene, lower diagnostic yield |
| Methodology | NGS + IHC + Fragment/STR Analysis | PCR or Sanger sequencing |
| Turnaround Time | 10 working days from Tuesday sample receipt | Variable, often longer |
Physician Insight & Safety Protocols
โAs a specialist in diagnostic radiology closely involved in oncologic imaging and tissue characterization, I understand the critical need for precise molecular profiling to guide targeted therapies. This gene panel delivers comprehensive data, but results must always be interpreted alongside your full clinical picture and imaging studies. Our dedicated team provides detailed telephonic guidance to ensure you and your oncologist fully grasp the implications.โ โ Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011.
Advisory Clinical Considerations
Safety Exclusion Criteria & ER Red Flags
- Specimen with <10% tumor cellularity will be rejected; inadequate tissue may delay critical treatment. Contact your oncologist immediately if you experience sudden worsening symptoms like severe abdominal pain, obstruction, or bleedingโthese require ER evaluation, not test waiting.
- Patients currently receiving chemotherapy or targeted therapy may have altered tissue quality; coordinate with your oncology team.
- This test is not a substitute for emergency care. Go to the nearest emergency department if you have signs of bowel perforation, severe vomiting, or high fever.
Patient Exclusion & Contraindications
Contraindications for Submission
- FFPE block with insufficient tumor content (<10%) or necrotic tissue will be rejected.
- Specimens not accompanied by the mandatory NGS Requisition Form (Form 40) cannot be processed.
- This test does not replace ongoing oncology management; do not discontinue prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
1. What is the purpose of the Cancer Targeted Gene Panel for colon/colorectal cancer?
This NGS panel identifies actionable mutations in genes like KRAS, NRAS, BRAF, and MSI status to guide targeted therapy selection and prognosis in colorectal cancer patients with over 99% sensitivity.
2. How should I prepare the tissue block for submission?
Submit a formalin-fixed paraffin-embedded (FFPE) block containing at least 10% tumor tissue, along with the mandatory NGS Requisition Form (Form 40), shipped at room temperature by Tuesday 9 am for the optimal 10-day reporting cycle.
3. How do I verify insurance coverage and arrange specimen pickup?
Contact our UAE team via WhatsApp at +971 54 548 8731 for direct insurance billing verification and to schedule a secure courier pickup of your archival tissue specimen, available daily from 8 AM to 11 PM.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
Your health data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
DNA Labs UAE is a DHA-licensed facility (License No. 1143) operating under strict ISO accreditations. Your genetic information remains confidential and is used solely for diagnostic purposes with explicit patient consent. For any privacy concerns, contact our Data Protection Officer.
Clinical & Logistical Metadata
| Test Name | Cancer Targeted Gene Panel (Colon/Colorectal) โ NGS + IHC |
| Price (AED) | 2,700 AED |
| Turnaround Time | 10 working days from Tuesday sample receipt |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) tissue block or slides โ Archival Tissue Specimen. Hospital Extraction Only โ Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. |
| Methodology Used | Next-Generation Sequencing (NGS) + Immunohistochemistry (IHC) + Fragment/STR Analysis |
| ICD-10-CM Code | C18.9 (Malignant neoplasm of colon, unspecified), C20 (Malignant neoplasm of rectum) |
| LOINC Code | 92916-2 (Colorectal cancer targeted gene panel) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians